The functional variant of the CLC-Kb channel T481S is not associated with blood pressure or hypertension in Swedes

Journal of Hypertension

Volumn 25, Issue 1, 2007, Pages 111-116

  Fava, Cristiano ^a,b,c   Montagnana, Martina ^a,b   Almgren, Peter ^a   Rosberg, Lena ^a   Guidi, Gian Cesare ^b   Berglund, Göran ^a   Melander, Olle ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c Department of Medicine   (Italy)

Author keywords

Association; Blood pressure; Chloride channel Kb; Genetics; Hypertension; Kidney

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHLORIDE CHANNEL; SERINE; THREONINE;

ADULT; AGE; ALLELE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; GENE ACTIVATION; GENE EXPRESSION; GENETIC POLYMORPHISM; HEALTH SURVEY; HOMOZYGOTE; HUMAN; HYPERTENSION; KIDNEY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SWEDEN; SYSTOLIC BLOOD PRESSURE;

EID: 33845367917     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280103a5a     Document Type: Article

References (24)

1. Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999; 340:1221-1227.
2. Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension: short review of the evidence. Hypertension 2003; 41:1000-1005.
3. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
4. Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth H. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 2000; 48:754-758.
5. Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N, et al. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 2003; 63:24-32.
6. Greger R. Ion transport mechanisms in thick ascending limb of Henle's loop of mammalian nephron. Physiol Rev 1985; 65:760-797.
7. O'Shaunghnessy K, Karet F. Sal handling and hypertension. J Clin Invest 2004; 113:1075-1081.
8. Jeck N, Waldegger P, Doroszewicz J, Seyberth H, Waldegger S. A common sequence variation of the CLCNKB gene strongly activates ClC-Kb chloride channel activity. Kidney Int 2004; 65:190-197.
9. Jeck N, Waldegger S, Lampert A, Boehmer C, Waldegger P, Lang PA, et al. Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension 2004; 43:1175-1181.
10. Berglund G, Elmstahl S, Janzon L, Larsson SA. The Malmo Diet and Cancer Study Design and feasibility. J Intern Med 1993; 233:45-51.
11. Berglund G, Eriksson KF, Israelsson B, Kjellstrom T, Lindgarde F, Mattiasson I, et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmo Preventive Project. J Intern Med 1996; 239:489-497.
12. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21:1779-1786.
13. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 2003; 41:207-210.
14. Hunt SC, Ellison RC, Atwood LD, Pankow JS, Province MA, Leppert MF. Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2002; 40:1-6.
15. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270:713-724.
16. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999; 14:143-149.
17. Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A, Yamawaki H, et al. Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population. Circ J 2005; 69:138-142.
18. Benjafield AV, Wang WYS, Speirs HJL, Morris BJ. Genome-wide scan for hypertension in Sydney sibships: The GENIHUSS Study. Am J Hypertens 2005; 18:828-832.
19. Speirs HJ, Wang WY, Benjafield AV, Morris BJ. No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36. J Hypertens 2005; 23:1491-1496.
20. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363-2369.
21. Menotti A, Lanti M, Kafatos A, Nissinen A, Dontas A, Nedeljkovic S, et al. The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Study. J Hypertens 2004; 22:1683-1690.
22. Pechere-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004; 17:994-1001.
23. Grobbee DE. Methodology of sodium sensitivity assessment. The example of age and sex. Hypertension 1991; 17:I109-I114.
24. Redon J. Hypertension in obesity. Nutr Metab Cardiovasc Dis 2001; 11:344-353.